Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

158.51 +1.96 (+1.25%)

Streaming Delayed Price Updated: 3:05 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗

November 20, 2023

ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.

Via Talk Markets

Topics ETFs

3 Biotech Stocks That Could Boom or Bust by 2025 ↗

November 16, 2023

Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.

Via InvestorPlace

Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech ↗

November 01, 2023

Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.

Via Talk Markets

This Week’s Data Dump May Lead To More Stock Market Pain ↗

October 29, 2023

This week will feature data that is not only going to move the markets, but also set the tone for fourth-quarter GDP growth. This means the dollar and rates will be more volatile, and the equity market...

Via Talk Markets

It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy ↗

October 24, 2023

The market's dour reaction to Roivant Sciences' latest deal doesn't add up.

Via The Motley Fool

Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗

October 23, 2023

The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...

Via Talk Markets

Topics Economy

Thoughts For Thursday: War Worries Rattle The Market ↗

October 19, 2023

Via Talk Markets

Too Much To Handle For Stocks As Rates Continue To Rise ↗

October 18, 2023

Stocks finished sharply lower as rates reached new cycle highs on the long end of the curve, and the yield curve steepened. This led to a drop of about 1.3% on the S&P 500, bringing the index down to...

Via Talk Markets

Topics Economy Stocks

Stocks and Bonds Go Their Separate Ways ↗

October 16, 2023

Stocks were up today by around 1.1% on the S&P 500, but we have gone nowhere now in a week, so the bulls are making no progress.

Via Talk Markets

Topics Stocks

Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up ↗

October 09, 2023

Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment.

Via Talk Markets

Stocks Rally And Rates Drop But Trends Remain In Place ↗

October 04, 2023

Stocks increased on Wednesday, rising by around 80 bps, as the dollar and rates fell. There is still a lot of data to come this week, with the Job report on Friday now front and center.

Via Talk Markets

Don’t Miss the Boom: 3 ETFs Set to Explode Higher ↗

September 27, 2023

The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate.

Via InvestorPlace

Topics ETFs

Healthcare Playbook Revisited - Growth Plus Value ↗

September 13, 2023

Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on.

Via Talk Markets

Buy List Alert: 3 Pharma Stocks with Positive Trial Updates ↗

September 13, 2023

These three pharma stocks could be driven higher amidst future revenue prospects as they report to investors positive clinical developments.

Via InvestorPlace

EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug ↗

September 08, 2023

Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.

Via Benzinga

Healthcare Portfolio: A Mixed Market Looking for Value ↗

September 05, 2023

Many healthcare stocks may be defensive in nature but if you are overweight the basic plays like the XLV or biotech funds like the Fidelity Biotechnology Fund you are trailing the market over the past...

Via Talk Markets

Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? ↗

August 30, 2023

It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months.

Via Talk Markets

Topics ETFs

If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now ↗

August 25, 2023

Roivant stock has outperformed the broader market and the biotech sector this year, mirroring the rise in the fortunes of its founder Vivek Ramaswamy.

Via Benzinga

3 Sorry Pharma Stocks to Sell in August Before It’s Too Late ↗

August 22, 2023

Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.

Via InvestorPlace

5 Meme Stocks to Sell Immediately, According to AI ↗

August 22, 2023

As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.

Via InvestorPlace

Topics Artificial Intelligence

Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗

July 17, 2023

Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.

Via Talk Markets

3 Biotech Stocks to Buy for Long-Term Gains

July 13, 2023

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.

Via MarketBeat

Topics ETFs Economy

“The Secret To Happiness” Stock Market (And Sentiment Results) ↗

July 06, 2023

There’s an old maxim, “the secret to happiness is low expectations”. This saying could not apply more directly than to what we are seeing coming into the Q2 earnings season.

Via Talk Markets

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

Biotech Blues: Stay Balanced Through July Earnings Season ↗

July 05, 2023

Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.

Via Talk Markets

Stocks May Suffer With Rates On The Cusp Of A Surge Higher ↗

July 03, 2023

It will be a holiday-shortened trading week, with today being a half day, and the market being closed on Tuesday. This will be a hectic week with a lot of data. Starting Monday with the ISM data for...

Via Talk Markets

The June Job Report Could Push Rates Sharply Higher ↗

July 01, 2023

This week's June job report could cause rates, the dollar, and even oil to all rise sharply.

Via Talk Markets

Biotech And Healthcare Stocks Lagging ↗

June 21, 2023

Healthcare is a laggard with XLV down YTD but UNH is still a core position.

Via Talk Markets

“The One That Got Away” Stock Market (And Sentiment Results) ↗

June 08, 2023

It was very lonely being a bull last fall when the S&P 500 was in the 3600s to 3700s. The good news is there’s plenty of runway ahead. The bad news is, it’s going to be a bit more tricky.

Via Talk Markets

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.